Forum for Science, Industry and Business
  • Sponsored by:
  • Siemens
  • Siemens
  • Siemens
Search our Site:

Topic (optional):

 

Home Reports Life Sciences Content

Key to stem cell transplant success is tricking immune system

next article
09.09.2005

 


Tricking the body’s immune system into ignoring stem cells will be the key to successful stem cell transplants, according to Professor Maggie Dallman, Imperial College London, speaking today at the BA Festival of Science.

Professor Dallman is investigating how to trick the body into producing regulatory cells, which prevent the body’s immune system from attacking its own molecules, at the site of a stem cell transplant. If they were present when stem cells were introduced into the body, the regulatory cells would inhibit the body’s natural response to ‘foreign’ cells, meaning the stem cells would be accepted.


Drug therapies can prevent traditional organ grafts from being destroyed in the short term but organ transplants typically fail after a number of years as the body’s immune system rejects the new tissue. Scientists are hopeful that harnessing regulatory cells would prevent stem cell transplants from facing similar rejection.

Professor Dallman, from Imperial’s Division of Cell and Molecular Biology, explains: “Stem cell transplants will offer fantastic possibilities for helping people with any disease where there is tissue damage or degeneration. It is vital to work out how to prevent these transplants from being rejected.

“We know from over 50 years of experience with transplants that a major issue affecting the success of such procedures is the immune system’s rejection of grafted tissue. Our recent experiments suggest that we could use regulatory cells to stop the immune system responding to foreign transplants, whilst leaving the rest of the immune system intact”, she adds.

Cloning stem cells using a patient’s own cells is another option for preventing the rejection of stem cell transplants. This would have a low risk of rejection since cloned cells would contain the patient’s own DNA. However, the cost and intricate nature of this procedure means that it may not prove to be a practical option for widespread use, according to Professor Dallman.

Laura Gallagher | Source: alphagalileo
Further information: www.imperial.ac.uk

next article

More articles from Life Sciences:

nachricht Hope for Alzheimer’s Patients?
04.12.2008 | Angewandte Chemie International Edition

nachricht New "Control Knobs" for Stem Cells Identified
04.12.2008 | Tufts University

B2B Search

Product / Service
Company / Organisation

Latest News

New solutions enhancing road safety developed in Finland

04.12.2008 | Transportation and Logistics

Why is the Earth’s mantle conductive?

04.12.2008 | Earth Sciences

ESA satellites flying in formation

04.12.2008 | Physics and Astronomy

Event News

Dublin to host Europe’s largest interdisciplinary science conference in 2012

28.11.2008 | Event News

ECREA Barcelona 2008

28.11.2008 | Event News

The Automobile – The Transition from Energy Guzzler to Power Supplier

20.11.2008 | Event News